Yahoo Finance reporter Anjalee Khemlani shares the latest updates on Pfizer's COVID booster, which could soon be approved for children ages 5-11.
The following are the top stories in the Wall Street Journal. - Pfizer Inc and BioNTech SE asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years. - Ford Motor Co is asking a Georgia court for a new trial, after a jury reached a $1.7 billion verdict against the auto maker last month involving a truck rollover accident that left two people dead.
Pfizer (PFE) closed the most recent trading day at $43.83, moving -0.57% from the previous trading session.